ArticleEuropean journal of medical research2026
A multicenter deep learning framework integrating radiomics and vision transformers for comprehensive ovarian tumor analysis from ultrasound imaging.
Article in European journal of medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Machine Learning for Radiomics in Oncology: Challenges, Limitations, and Future Directions.Sensors (Basel, Switzerland) · 2026Article
- Ovarian tissue quality assessment and fertility preservation strategies enabled by multi-omics and artificial intelligence: current applications and clinical perspectives.Frontiers in physiology · 2026Review
- AI-mediated ultrasound radiomics in the diagnosis and treatment of triple-negative breast cancer: research progress and future challenges.Frontiers in oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to develop and validate a robust multicenter deep learning pipeline that integrates radiomic descriptors with deep feature embeddings to enable comprehensive ovarian tumor analysis from ultrasound imaging, encompassing segmentation, multi-class classification, and prognostic prediction.
methodsUltrasound data from 3156 patients across eight centers were retrospectively analyzed. Five segmentation networks (UNETR, nnU-Net, Swin-UNet, SegNet, UNet) were trained to delineate tumors. From segmented regions, handcrafted radiomic features and deep features (ResNet, Vision Transformer (ViT)) were extracted. After reproducibility filtering (intraclass correlation coefficient (ICC) ≥ 0.75) and dimensionality reduction (PCA, RFE, ANOVA), three classifiers (TabTransformer, MLP, XGBoost) were trained for six-class categorization. Progression-free survival (PFS) was predicted using regression models. External validation was performed on 756 patients.
resultsUNETR achieved the best segmentation performance (DSC: 96.2%). For classification, the combined feature model with RFE and TabTransformer reached the highest accuracy (training AUC: 98.0%; external AUC: 95.8%; accuracy: 94.0%). For prognosis, TabTransformer achieved the best performance (C-index: 0.847), with consistent generalization across centers. Kaplan-Meier analysis confirmed significant survival group separation (p < 0.001).
conclusionThe proposed framework shows strong potential to reduce inter-operator variability and support personalized clinical decision-making in ovarian cancer care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.